Abstract:Abstract Background Foot-and-mouth disease (FMD) is a highly transmissible disease that leads to vast economic losses in many countries. Prevention using inactivated vaccines is one effective measure used to control FMD. Unfortunately, inactivated FMD vaccines provide only short-term protection and require a cold-chain system. In recent years, many studies have shown that layered double metal hydroxides (LDHs) carrying antigens can be used to strongly induce immune responses. In this study, LDH nanoparticles (NPs) were prepared by hydrothermal synthesis. LDH particle size, electric potential, and morphology were measured and observed. The adsorption capacity of LDH NPs to FMDV was tested. The effects of LDH as an adjuvant on inactivated FMDV vaccines were further evaluated and compared with commercial FMDV Montanide ISA-206 in BALB/C female mice and Yorkshire pigs. Results LDH NPs were successfully prepared with a uniform particle size of ~ 87.21 nm, regular edges, a loose hexagonal shape and positive zeta charge of 32 mV. The maximum absorption concentration was 0.16–0.31 μg FMDV/μg LDH. In the mouse experiment, antibody levels in group LDH + FMDV were significantly higher compared to group saline + FMDV ( P < 0.01) from days 42–98 and were significantly higher to group ISA-206 + FMDV on day 56 post-immunization ( P < 0.05). After day 14 post-immunization, IFN-γ content was significantly increased ( P < 0.05). In the pig experiment, antibody levels in both the ISA-206 + FMDV and LDH + FMDV were positive and were significantly higher compared with the PBS group on day 7 ( P < 0.005). Antibody levels in 90% pigs were positive on day 56 in the LDH group. The neutralizing antibody levels in the LDH and ISA-206 groups were significantly higher from days 7–28 compared to the PBS control group ( P < 0.05). Thus, LDH NPs were effective at inducing an immune response against FMDV. Conclusions LDHs with a loose hexagonal shape and a positive charge were prepared and evaluated as adjuvant for FMD vaccine. It was demonstrated that LDHs can induce immune responses in mice and pigs. In addition, the LDHs produced antibodies continuously which may indicate a slow-release effect. The study shows that LDHs may act as a potentially useful FMDV adjuvant.

Double synergic chitosan-coated poly (lactic-co-glycolic) acid nanospheres loaded with nucleic acids as an intranasally administered vaccine delivery system to control the infection of foot-and-mouth disease virus

A Novel Mucosal Vaccine Against Foot-and-Mouth Disease Virus Induces Protection in Mice and Swine

Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant.

Dendritic cell-based biomimetic nanoparticles for foot-and-mouth disease induce robust cellular immunity

Local and systemic immune responses induced by intranasal immunization with biomineralized foot-and-mouth disease virus-like particles

Development and Efficacy Evaluation of a Novel Nano-Emulsion Adjuvant for a Foot-and-Mouth Disease Virus-like Particles Vaccine Based on Squalane

Chitosan-based systems for intranasal immunization against foot-and-mouth disease

A ferritin-based nanoparticle displaying a neutralizing epitope for foot-and-mouth disease virus (FMDV) confers partial protection in guinea pigs

Immunogenicity Evaluation of MS2 Phage-Mediated Chimeric Nanoparticle Displaying an Immunodominant B Cell Epitope of Foot-and-mouth Disease Virus.

Enhancement of Serological Immune Responses to Foot-And-Mouth Disease Vaccine by A Supplement Made of Extract of Cochinchina Momordica Seeds

Interleukin-15 Enhance DNA Vaccine Elicited Mucosal and Systemic Immunity Against Foot and Mouth Disease Virus

Poly(I:C) Combined with Multi-Epitope Protein Vaccine Completely Protects Against Virulent Foot-and-mouth Disease Virus Challenge in Pigs

Protection of a Novel Epitope-Rna VLP Double-Effective VLP Vaccine for Foot-and-mouth Disease.

Potent immune responses against thermostable Foot-and-Mouth disease virus VP1 nanovaccine adjuvanted with polymeric thermostable scaffold

Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs

Enhancement of the gut mucosal immunity and immune response to the foot-and-mouth disease vaccine by oral administration of astragalus polysaccharide

Enhanced Immunogenicity of Foot and Mouth Disease DNA Vaccine Delivered by PLGA Nanoparticles Combined with Cytokine Adjuvants

Oral Immunization of FMDV Vaccine Using Ph-Sensitive and Mucoadhesive Thiolated Cellulose Acetate Phthalate Microparticles

Construction of Genetically Engineered Vaccine Candidate of Type O Foot-and-Mouth-Disease Virus of Pig and Analysis of Its Immunogenicity

Preparation of a Polysaccharide Adjuvant and Its Application in the Production of a Foot-and-mouth Disease Virus-Like Particles Vaccine

Study on MS2 Mediated Virus-like Particles Vaccine Against Foot-and-month Disease